ProQR Therapeutics N.V. (Nasdaq: PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for severe ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot FDA News Management Comments

ProQR (PRQR) Prices 9.09M Share Offering at $5.50/ShOctober 16, 2019 5:48 AM ProQR (PRQR) Announces Proposed $50M Share Common OfferingOctober 15, 2019 4:14 PM ProQR Receives Rare Pediatric Disease Designation from FDA for Sepofarsen for the Treatment of LCA10October 15, 2019 4:08 PM